| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A nanotherapeutic system for gastric cancer suppression by synergistic chemotherapy and immunotherapy based on iPSCs and DCs exosomes
|
Li, Yezhou
|
|
|
72 |
6 |
p. 1673-1683
|
artikel
|
| 2 |
Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sites
|
Martin, Alexandra L.
|
|
|
72 |
6 |
p. 1445-1460
|
artikel
|
| 3 |
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
|
Silk, Ann W.
|
|
|
72 |
6 |
p. 1405-1415
|
artikel
|
| 4 |
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis
|
Wong, Alex
|
|
|
72 |
6 |
p. 1727-1735
|
artikel
|
| 5 |
BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study
|
Friedhoff, Jana
|
|
|
72 |
6 |
p. 1603-1618
|
artikel
|
| 6 |
CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma
|
Kim, Jeong Ryeol
|
|
|
72 |
6 |
p. 1567-1580
|
artikel
|
| 7 |
Combination of magnetic hyperthermia and immunomodulators to drive complete tumor regression of poorly immunogenic melanoma
|
Nishikawa, Ami
|
|
|
72 |
6 |
p. 1493-1504
|
artikel
|
| 8 |
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis
|
Santoni, Matteo
|
|
|
72 |
6 |
p. 1365-1379
|
artikel
|
| 9 |
Comprehensive analysis of immune subtypes reveals the prognostic value of cytotoxicity and FAP+ fibroblasts in stomach adenocarcinoma
|
Wang, Xin
|
|
|
72 |
6 |
p. 1763-1778
|
artikel
|
| 10 |
Correction: Association between pre‑treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis
|
Wong, Alex
|
|
|
72 |
6 |
p. 1737
|
artikel
|
| 11 |
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
|
García-Corbacho, Javier
|
|
|
72 |
6 |
p. 1725-1726
|
artikel
|
| 12 |
Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinoma
|
Lu, Tong
|
|
|
72 |
6 |
p. 1751
|
artikel
|
| 13 |
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
|
Pons-Tostivint, E.
|
|
|
72 |
6 |
p. 1891-1892
|
artikel
|
| 14 |
CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer
|
Wu, Lei
|
|
|
72 |
6 |
p. 1479-1492
|
artikel
|
| 15 |
Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate
|
Burrack, Adam L.
|
|
|
72 |
6 |
p. 1461-1478
|
artikel
|
| 16 |
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
|
García-Corbacho, Javier
|
|
|
72 |
6 |
p. 1709-1723
|
artikel
|
| 17 |
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers
|
Fiore, Piera Filomena
|
|
|
72 |
6 |
p. 1417-1428
|
artikel
|
| 18 |
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial
|
Shiota, Masaki
|
|
|
72 |
6 |
p. 1903-1915
|
artikel
|
| 19 |
Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort study
|
Chiang, Cho-Han
|
|
|
72 |
6 |
p. 1951-1956
|
artikel
|
| 20 |
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib
|
Häselbarth, Lukas
|
|
|
72 |
6 |
p. 1661-1672
|
artikel
|
| 21 |
Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinoma
|
Lu, Tong
|
|
|
72 |
6 |
p. 1739-1750
|
artikel
|
| 22 |
Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo
|
Martomo, Stella A.
|
|
|
72 |
6 |
p. 1941-1950
|
artikel
|
| 23 |
Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages
|
Ehlers, Femke A. I.
|
|
|
72 |
6 |
p. 1789-1801
|
artikel
|
| 24 |
First-line therapy for elderly patients with advanced renal cell carcinoma in the immuno-oncology era: a network meta-analysis
|
Fujiwara, Yu
|
|
|
72 |
6 |
p. 1355-1364
|
artikel
|
| 25 |
Human γδ T cells induce CD8+ T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK
|
Wang, Shengdong
|
|
|
72 |
6 |
p. 1803-1821
|
artikel
|
| 26 |
Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study
|
Rizzo, Alessandro
|
|
|
72 |
6 |
p. 1381-1394
|
artikel
|
| 27 |
Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy
|
Wang, Chunhua
|
|
|
72 |
6 |
p. 1685-1698
|
artikel
|
| 28 |
Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma
|
Liu, Zhonglong
|
|
|
72 |
6 |
p. 1505-1521
|
artikel
|
| 29 |
Lactate from glycolysis regulates inflammatory macrophage polarization in breast cancer
|
Wang, Chao
|
|
|
72 |
6 |
p. 1917-1932
|
artikel
|
| 30 |
LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma
|
Zhao, Fen
|
|
|
72 |
6 |
p. 1835-1851
|
artikel
|
| 31 |
Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab
|
Siemiątkowska, Anna
|
|
|
72 |
6 |
p. 1853-1863
|
artikel
|
| 32 |
NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma
|
Chen, Lei
|
|
|
72 |
6 |
p. 1647-1660
|
artikel
|
| 33 |
PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
|
Al-Mterin, Mohammad A.
|
|
|
72 |
6 |
p. 1933-1939
|
artikel
|
| 34 |
Pharmacological potentiation of monocyte-derived dendritic cell cancer immunotherapy
|
Poirier, Alexandre
|
|
|
72 |
6 |
p. 1343-1353
|
artikel
|
| 35 |
Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment
|
Guo, Zhi-chen
|
|
|
72 |
6 |
p. 1523-1539
|
artikel
|
| 36 |
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer
|
Morimoto, Kenji
|
|
|
72 |
6 |
p. 1699-1707
|
artikel
|
| 37 |
Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients
|
Fang, Bangwei
|
|
|
72 |
6 |
p. 1541-1551
|
artikel
|
| 38 |
Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma
|
Wakasu, Sho
|
|
|
72 |
6 |
p. 1823-1834
|
artikel
|
| 39 |
Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma
|
Anno, Tadatsugu
|
|
|
72 |
6 |
p. 1779-1788
|
artikel
|
| 40 |
Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells
|
Wang, Chih-Liang
|
|
|
72 |
6 |
p. 1865-1880
|
artikel
|
| 41 |
Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence
|
Liu, Qin-qin
|
|
|
72 |
6 |
p. 1753-1761
|
artikel
|
| 42 |
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%
|
Pons-Tostivint, E.
|
|
|
72 |
6 |
p. 1881-1890
|
artikel
|
| 43 |
Refurbishment of NK cell effector functions through their receptors by depleting the activity of nTreg cells in Dalton’s Lymphoma-induced tumor microenvironment: an in vitro and in vivo study
|
Tomar, Munendra Singh
|
|
|
72 |
6 |
p. 1429-1444
|
artikel
|
| 44 |
Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment
|
Wang, Xiaoyuan
|
|
|
72 |
6 |
p. 1619-1631
|
artikel
|
| 45 |
TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses
|
Harris, Rebecca
|
|
|
72 |
6 |
p. 1581-1601
|
artikel
|
| 46 |
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer
|
Santegoets, Saskia J.
|
|
|
72 |
6 |
p. 1553-1565
|
artikel
|
| 47 |
Treatment options for unresectable hepatocellular carcinoma with hepatitis virus infection following sorafenib failure
|
Li, Xiaomi
|
|
|
72 |
6 |
p. 1395-1403
|
artikel
|
| 48 |
Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma
|
Oladejo, Mariam
|
|
|
72 |
6 |
p. 1633-1646
|
artikel
|
| 49 |
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors
|
Friedman, Joshua S.
|
|
|
72 |
6 |
p. 1893-1901
|
artikel
|
Tijdschrift beschrijving